TrialThe lancet. Gastroenterology & hepatology2022

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study.

Aurelien Marabelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.